Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DDR1-Induced Paracrine Factors of Hepatocytes Promote HSC Activation and Fibrosis Development. | Curr Mol Pharmacol | 2024 | 36809965 | PubTator, text mining | PubMed |
| Preclinical characterization of CPL304110 as a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3 for gastric, bladder, and squamous cell lung cancer. | Front Oncol | 2023 | 38282676 | PubTator, text mining | PubMed |
| Limitations and potential of immunotherapy in ovarian cancer. | Front Immunol | 2023 | 38264664 | PubTator, text mining | PubMed |
| Targeting ion channels with ultra-large library screening for hit discovery. | Front Mol Neurosci | 2023 | 38249296 | PubTator, text mining | PubMed |
| Discoidin domain receptors; an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism. | Front Dent Med | 2023 | 38222874 | PubTator, text mining | PubMed |
| Exosomal ITGB6 from dormant lung adenocarcinoma cells activates cancer-associated fibroblasts by KLF10 positive feedback loop and the TGF-β pathway. | Transl Lung Cancer Res | 2023 | 38205211 | PubTator, text mining | PubMed |
| Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib. | J Clin Med | 2023 | 38202039 | PubTator, text mining | PubMed |
| Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential. | Cancers (Basel) | 2023 | 38201551 | PubTator, text mining | PubMed |
| Systems genetics uncover new loci containing functional gene candidates in Mycobacterium tuberculosis-infected Diversity Outbred mice. | bioRxiv | 2023 | 38187647 | PubTator, text mining | PubMed |
| AMGDTI: drug-target interaction prediction based on adaptive meta-graph learning in heterogeneous network. | Brief Bioinform | 2023 | 38145949 | PubTator, text mining | PubMed |
| MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells. | ACS Omega | 2023 | 38144074 | PubTator, text mining | PubMed |
| A Critical Interpretive Synthesis of the Role of Arecoline in Oral Carcinogenesis: Is the Local Cholinergic Axis a Missing Link in Disease Pathophysiology? | Pharmaceuticals (Basel) | 2023 | 38139811 | PubTator, text mining | PubMed |
| Insights into the Tumor Microenvironment-Components, Functions and Therapeutics. | Int J Mol Sci | 2023 | 38139365 | PubTator, text mining | PubMed |
| PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma. | Int J Mol Sci | 2023 | 38139175 | PubTator, text mining | PubMed |
| Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors. | Cancers (Basel) | 2023 | 38136399 | PubTator, text mining | PubMed |
| Altered Treg Infiltration after Discoidin Domain Receptor 1 (DDR1) Inhibition and Knockout Promotes Tumor Growth in Lung Adenocarcinoma. | Cancers (Basel) | 2023 | 38136314 | PubTator, text mining | PubMed |
| Genetic and observational associations of lung function with gastrointestinal tract diseases: pleiotropic and mendelian randomization analysis. | Respir Res | 2023 | 38102678 | PubTator, text mining | PubMed |
| Cheminformatics and artificial intelligence for accelerating agrochemical discovery. | Front Chem | 2023 | 38093816 | PubTator, text mining | PubMed |
| The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis. | J Inflamm Res | 2023 | 38088943 | PubTator, text mining | PubMed |
| Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells. | Life Sci | 2023 | 38084671 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=12